1. Home
  2. COLD vs HAE Comparison

COLD vs HAE Comparison

Compare COLD & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$12.41

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.62

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLD
HAE
Founded
1903
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
2018
1991

Fundamental Metrics

Financial Performance
Metric
COLD
HAE
Price
$12.41
$57.62
Analyst Decision
Hold
Buy
Analyst Count
13
9
Target Price
$14.85
$86.00
AVG Volume (30 Days)
4.5M
1.1M
Earning Date
02-19-2026
02-05-2026
Dividend Yield
7.44%
N/A
EPS Growth
N/A
43.84
EPS
N/A
3.65
Revenue
$2,607,407,000.00
$1,318,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.86
P/E Ratio
N/A
$15.82
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$47.32
52 Week High
$23.52
$87.32

Technical Indicators

Market Signals
Indicator
COLD
HAE
Relative Strength Index (RSI) 43.80 22.70
Support Level $12.02 $55.95
Resistance Level $12.98 $60.50
Average True Range (ATR) 0.43 2.46
MACD -0.06 -0.59
Stochastic Oscillator 29.11 14.35

Price Performance

Historical Comparison
COLD
HAE

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: